New Market Report: Nigeria Pharmaceuticals & Healthcare Report Q2 2015
Nigeria's pharmaceutical and healthcare markets are vastly underdeveloped by Western standards as poor infrastructure, a weak regulatory system and lack of specialised facilities weaken growth potential. However, the Nigerian government's continuing efforts to expand healthcare access through national health insurance by introducing mobile registration and a community-based healthcare programme will provide revenue-earning opportunities for drug-makers. We believe developments along with new efforts to reduce the volume of counterfeit medicines in circulation will help boost pharmaceutical expenditure in the country.
View full press release